Lilly Pharmaceutical Company - Search News

Prediction: This Is What Eli Lilly Stock Will Do Next (Hint: It's Not a Stock Split)

With a market capitalization of over $800 billion, Eli Lilly (NYSE: LLY) is the largest pharmaceutical company in the world. Much that is thanks to the rise of glucagon-like peptide-1 (GLP-1) agonists such as Mounjaro and Zepbound, which are fueling a new wave of growth for the company.

Hosted on MSN · 3d

Eli Lilly and Company (LLY): Hedge Funds Are Bullish On This Counter Cyclical and Defensive Stock to Invest In

YAHOO!Finance · 4d

Eli Lilly and Company (LLY): Among Morgan Stanley’s Best Stock Picks for 2025

We recently compiled a list of Morgan Stanley’s Best Stock Picks: 15 Stocks To Own For 2025. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against Morgan Stanley’s other stock picks.

Zacks.com on MSN · 4d

Is Most-Watched Stock Eli Lilly and Company (LLY) Worth Betting on Now?

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over the past month,

11don MSN

Eli Lilly’s new CFO is a 23-year company veteran—showing how pharma firms rely on a ‘deep bench of qualified talent’

Ashkenazi was CFO at Lilly from 2021 until leaving the company this summer. Like Montarce, she joined Lilly in 2001. During ...

7h

Eli Lilly Is Finally Cheap, Warranting An Upgrade To Buy

Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

23hon MSN

Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today

The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.

5d

Drug Companies Are Embracing Direct-To-Consumer Sales. That's A Win For Patients.

For too long, middlemen like pharmacy benefit managers have taken advantage of the complexity of the drug supply chain to ...

12h

Eli Lilly: Sticking With A $1000 Target Ahead Of Q3 Earnings, New Trading Range

Eli Lilly surged 58% in 2024, driven by weight-loss drugs and strong earnings. The technical chart shows consolidation. See ...

Eli Lilly requests records of people who took copies of its weight-loss drug

The letter is the latest sign that the battle between the brand-name drug manufacturers and the companies that make and sell ...

3d

Eli Lilly urges court to toss $183 mln Medicaid fraud judgment

Drugmaker Eli Lilly on Wednesday urged a federal appeals court to overturn a $183 million judgment against it in a case ...

1d

Eli Lilly’s Competitive Edge in Weight Loss Medication Market Bolstered by Orforglipron’s Promising Trial Results

Deutsche Bank analyst James Shin has maintained their bullish stance on LLY stock, giving a Buy rating on September 16. James Shin has given ...

19h

FTC sues drug middlemen over manipulating the insulin market

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

Pharmaceutical Technology on MSN5d

Lilly’s EBGLYSS gains FDA approval for patients aged 12 and older

Eli Lilly and Company has announced the FDA approval of EBGLYSS for treating atopic dermatitis in adults and children over 12 ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results